Vertex Pharmaceuticals: Balancing Growth Prospects and Uncertainties with a Hold Rating
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...
Vertex Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating
Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Vertex Pharmaceuticals Inc. closed $108.22 short of its 52-week high ($519.88), which the company achieved on November 8th.
Morningstar20h
Morningstar’s 2023 Annual US Fund Fee Study
Mutual fund investors have been saving billions of dollars in fund expenses thanks to the continued ... Download the report now to use our 2023 fund analysis to strengthen your clients’ portfolios.
Indiatimes10h
Ortin Labs - Ortin Global Share Price
Ortin Global Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 14.52 Crore) operating in Pharmaceuticals sector. Ortin Global Ltd. key Products/Revenue Segments ...
Indiatimes10h
Utique Enterprises Share Price
Utique Enterprises Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 38.92 Crore) operating in Financial Services sector. Utique Enterprises Ltd. key ...